News
Predica Diagnostics and TenWise announce collaboration on development of MicroBioDx, a novel microbiome-host profiling tool for health and disease
Leiden/Nijmegen - TenWise BV and Venture Challenge alumnus Predica Diagnostics BV have received financial support from the Dutch RVO (
Venture Challenge Winner Ambagon Therapeutics Raises $85mln Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline
San Fransisco / Eindhoven – Ambagon Therapeutics, a biotechnology company unlocking intrinsically disordered proteins and other difficult-to-target protein classes, today announced an $85 million Series A to augment its
SeraNovo and Graviton deepen collaboration and enter into a second license agreement to develop formulations for Graviton's ROCK-2 inhibitors
Venture Challenge Winner SeraNovo is pleased to announce the closing of a second license agreement with Graviton Bioscience Corporation (Graviton), a biopharmaceutical company engaged in the research and development of small molecules in the fields of oncol
NTRC announces IND approval for the TTK/PLK dual inhibitor BAL0891 in its collaboration with Swiss pharmaceutical company Basilea
Oss – Venture Challenge alumnus NTRC, specialized in discovery and development of innovative kinase inhibitors to treat cancer patients, today announces that the U.S.
ATRO Medical closes a new financing round for the Trammpolin® meniscus prosthesis
Nijmegen - Venture Challenge Alumnus ATRO Medical announces the successful closure of a €1,9 million financing round.
Venture Challenge alumnus Sirius Medical announces second closing of A-round financing to accelerate US expansion
Eindhoven, Netherlands – Sirius Medical, a leader in tumor navigation technology, announced today the closing of its second round of series A financing.
Venture Challenge Spring 2022 open for applications!
Curious what the Venture Challenge may bring you? This is what last year's alumni say about it.
Venture Challenge alumnus Nutrileads wins FI Europe Innovation Award
BeniCaros™ the proprietary immune health ingredient has won the FI Europe Innovation Award in the Health Innovation Category
Eureka Eurostars awarded to Venture Challenge Winner BIMINI Biotech
BIMINI Biotech was recently awarded a Eureka Eurostars project with the aim of targeting the growth hormone receptor for novel and personalized cancer therapeutics.
Venture Challenge alumnus CC Diagnostics appoints new CEO
CC Diagnostics is proud to announce the appointment of Ronald Vos as the companies Chief Executive Officer. Ronald brings over 30 years of busi